Top Markets
#1 ICON ICON +156.44%
#2 ZetaChain ZetaChain +47.92%
#3 Four Four +39.72%
#4 Phala Phala +34.53%
#5 Chia Chia +33.77%
#6 Mubarak Mubarak +32.15%
#7 Nano Nano +27.88%
#8 SODAX SODAX +26.10%
#9 Bitway Bitway +24.95%
#10 PumpMeme PumpMeme +23.83%
Coin of the day
ICON ICON
Configuración
Idioma
ESPAñOL
Moneda
USD
Tema
Zoetis Inc. Zoetis Inc.

Zoetis Inc.

ZTS
Clasificación en acciones #830
Zoetis Inc. stands as a global leader in animal health, focusing on the... Zoetis Inc. stands as a global leader in animal health, focusing on the research, development, manufacturing, and commercialization of veterinary pharmaceuticals, vaccines, and diagnostic tools. Its comprehensive portfolio serves a broad spectrum of species, encompassing both livestock, including cattle, swine, poultry, fish, and sheep, and beloved companion animals such as dogs, cats, and horses. Among its pharmaceutical offerings are various therapeutic agents. This includes vaccines, vital for preventing respiratory, gastrointestinal, and reproductive diseases by stimulating a targeted immune response; anti-infectives that combat or inhibit the proliferation of bacterial, fungal, or protozoal pathogens; and parasiticides aimed at eradicating both internal and external pests such as fleas, ticks, and various worms. Additional pharmaceuticals address areas such as pain management and sedation, anti-emesis, reproductive health, and oncology. The portfolio also features dermatological solutions for allergic skin conditions and atopic dermatitis, alongside medicated feed additives specifically designed for livestock. Beyond therapeutics, Zoetis offers an extensive array of diagnostic solutions. These include portable analysis systems for blood and urine, point-of-care testing devices, specialized instruments and reagents, rapid immunoassay kits, comprehensive reference laboratory services, and blood glucose monitoring equipment. Further extending its reach, the company provides supplementary offerings such as nutritional products, agribusiness support services, biodevices, genetic testing, and innovations in precision animal health. Zoetis distributes its diverse product portfolio to a broad customer base, including veterinary professionals, livestock producers, and retail channels. This distribution occurs directly via its sales representatives and technical specialists, as well as through partnerships with third-party veterinary distributors. Established in 1952, the company maintains its corporate headquarters in Parsippany, New Jersey.
Precio por acción
$71.40
Capitalización bursátil
$29.93B
Cambio (1 día)
-0.13%
Cambio (1 año)
-51.06%
País
US
Comercio Zoetis Inc. (ZTS)

Categoría

Healthcare
Ratio P/S de Zoetis Inc. (ZTS)
Ratio P/S al September 2026 TTM: 3.25
Según los informes financieros más recientes y el precio de las acciones de Zoetis Inc., el ratio P/S actual (TTM) es 3.25. Al final de 2023, el ratio P/S era 10.65.
Historial del ratio P/S de Zoetis Inc. desde 2009 hasta 2026
Ratio P/S al final de cada año
Año Ratio P/S Cambiar
2026 (TTM) 3.25 -59.43%
2024 8.00 -24.95%
2023 10.65 25.27%
2022 8.50 -42.87%
2021 14.89 26.27%
2020 11.79 16.63%
2019 10.11 42.50%
2018 7.09 6.67%
2017 6.65 22.50%
2016 5.43 8.03%
2015 5.03 11.53%
2014 4.51 25.73%
2013 3.58 0.22%
2012 3.58 2.09%
2011 3.50 -15.38%
2010 4.14 -22.95%
2009 5.37 0.00%
Ratio P/S de empresas similares o competidoras
Empresa Ratio P/S Diferencia del ratio P/S País
Eli Lilly and Company Eli Lilly and Company
Eli Lilly and Company
LLY.US
13.45 314.39%
US
Johnson & Johnson Johnson & Johnson
Johnson & Johnson
JNJ.US
6.55 101.93%
US
AbbVie Inc. AbbVie Inc.
AbbVie Inc.
ABBV.US
7.18 121.26%
US
Roche Holding AG Roche Holding AG
Roche Holding AG
RO.SW
4.66 43.53%
CH
Merck & Co., Inc. Merck & Co., Inc.
Merck & Co., Inc.
MRK.US
5.39 65.99%
US